| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





* CURE: Digestive Diseases Research Center, VA Greater Los Angeles Healthcare System, Los Angeles, California:
Digestive Diseases Division, University of California Los Angeles School of Medicine, Los Angeles, California; and
Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, California
Correspondence: Address reprint requests to David A. Keire, VA GLAHS, Bldg. 115, Rm. 111B, 11301 Wilshire Blvd., Los Angeles, CA 90073. Tel.: 310-478-3711, Ext. 41828; Fax: 310-268-4963; E-mail: dkeire{at}ucla.edu.
[D-Arg1, D-Trp5,7,9, Leu11] substance P (SPA) belongs to a family of peptides including antagonist G and SpD that act as broad-spectrum neuropeptide antagonists at several peripheral receptors. The lipid-induced structure of these peptides may be important for the receptor interactions of these analogs. Thus we describe the tertiary structure of SPA in the presence of sodium dodecylsulfate micelles at pH 5.0, and 25°C as determined from two-dimensional 1H-NMR data recorded at 500 MHz. The resulting three-dimensional structure can be generally described as two type IV nonstandard turns around Arg1*, Pro2, Lys3, and Pro4 and Gln6, Trp7*, Phe8, and Trp9* residues, respectively, inserted into the interfacial region of the micelles (the asterisks denote D-form amino acid). These turns juxtapose the N- and C-termini of SPA and may form the basis of this peptide's unique ability to inhibit peptide receptor interactions at multiple receptor types.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |